Pneumococcal conjugate second or third-dose vaccines (PCVc) in Mongolia
Mongolia: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 96.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Mongolia, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Mongolia is 96.0%, measured in 2025. That is the highest value across all 18 years on record.
Compared with earlier readings it is up 4.3% over five years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Mongolia peaked at 96.0% in 2023 and was at its lowest, 0.0%, in 2008.
Mongolia ranks 27th of 194 countries on this measure, in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Mongolia, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 0.0% | — |
| 2017 | 13.0% | — |
| 2018 | 26.0% | +100.0% |
| 2019 | 49.0% | +88.5% |
| 2020 | 92.0% | +87.8% |
| 2021 | 95.0% | +3.3% |
| 2022 | 94.0% | -1.1% |
| 2023 | 96.0% | +2.1% |
| 2024 | 96.0% | +0.0% |
| 2025 | 96.0% | +0.0% |
Mongolia compared with similar countries
- Mongolia's 96.0% is above the median for upper middle income countries, which is 76.0%, 1.3× the median. (57 countries reporting)
- Mongolia's 96.0% is above the median for East Asia & Pacific, which is 81.0%, 1.2× the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 8.8% | 0.0% | 49.0% | 10 |
| 2020s | 94.8% | 92.0% | 96.0% | 6 |
Countries ranked near Mongolia
More health data for Mongolia
- Un projection of annual infant deaths, annual growth rate -1.56 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6056 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 847.3 deaths per 1,000 people (2090)
- Number of infants who die before age 1 63 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.44 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0458 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.5 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Mongolia?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Mongolia was 96.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Mongolia?
- The highest recorded value was 96.0% in 2023.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Mongolia?
- The lowest recorded value was 0.0% in 2008.
- How does Mongolia rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Mongolia ranks 27th out of 194 countries with data for 2025.
- Where does this Mongolia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).